Immunoglobulin G Heavy Chain (Gm) Allotypes in Multiple Sclerosis

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1981 Jun 1

PMID 6787085

Citations 16

Authors

J P Pandey

J M Goust

J P Salier

H H Fudenberg

Affiliations

Soon will be listed here.

Abstract

Serum samples from 70 Caucasian patients with multiple sclerosis were typed for nine Gm markers. Significant association was found with the Gm 1,17;21 phenotype, and the relative risk for individuals with this phenotype was calculated at 3.6. The data indicate that Caucasians positive for Gm 1,17;21 are almost four times more likely to develop multiple sclerosis than those without this phenotype.

Citing Articles

Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer's disease in African Americans.

Pandey J, Nietert P, Namboodiri A, Bennett D, Barnes L Immunogenetics. 2024; 77(1):1.

PMID: 39489839 PMC: 11532319. DOI: 10.1007/s00251-024-01358-4.

Coming together at the hinges: Therapeutic prospects of IgG3.

Chu T, Patz Jr E, Ackerman M MAbs. 2021; 13(1):1882028.

PMID: 33602056 PMC: 7899677. DOI: 10.1080/19420862.2021.1882028.

The forgotten tale of immunoglobulin allotypes in cancer risk and treatment.

Pandey J, Li Z Exp Hematol Oncol. 2013; 2(1):6.

PMID: 23425356 PMC: 3598368. DOI: 10.1186/2162-3619-2-6.

Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis.

Buck D, Albrecht E, Aslam M, Goris A, Hauenstein N, Jochim A Ann Neurol. 2012; 73(1):86-94.

PMID: 23225573 PMC: 3661208. DOI: 10.1002/ana.23749.

Susceptibility to multiple sclerosis and the immunoglobulin heavy chain variable region.

Wood N, Sawcer S, Holmans P, Clayton D, Robertson N, Compston D J Neurol. 1995; 242(10):677-82.

PMID: 8568530 DOI: 10.1007/BF00866919.

References

WOOLF B . On estimating the relation between blood group and disease. Ann Hum Genet. 1955; 19(4):251-3. DOI: 10.1111/j.1469-1809.1955.tb01348.x. View

BERMAN P, Patrick J . Linkage between the frequency of muscular weakness and loci that regulate immune responsiveness in murine experimental myasthenia gravis. J Exp Med. 1980; 152(3):507-20. PMC: 2185932. DOI: 10.1084/jem.152.3.507. View

Norrby E, Link H, Olsson J, Panelius M, Salmi A, Vandvik B . Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis. Infect Immun. 1974; 10(4):688-94. PMC: 423007. DOI: 10.1128/iai.10.4.688-694.1974. View

Saito S, Naito S, Kawanami S, Kurowa Y . HLA studies on multiple sclerosis in Japan. Neurology. 1976; 26(6 PT 2):49. DOI: 10.1212/wnl.26.6_part_2.49. View

DuPont B, Lisak R, Jersild C, Hansen J, Silberberg D, Whitsett C . HLA antigens in black American patients with multiple sclerosis. Transplant Proc. 1977; 9(1 Suppl 1):181-5. View

Paul W, Benacerraf B . Functional specificity of thymus- dependent lymphocytes. Science. 1977; 195(4284):1293-300. DOI: 10.1126/science.320663. View

Wells J, Fudenberg H, Mackay I . RElation of the human antibody response to flagellin to GM genotype. J Immunol. 1971; 107(6):1505-11. View

Tourtellotte W, Ma B . Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis. Neurology. 1978; 28(9 Pt 2):76-83. DOI: 10.1212/wnl.28.9_part_2.76. View

VYAS G, Fudenberg H, Pretty H, Gold E . A new rapid method for genetic typing of human immunoglobulins. J Immunol. 1968; 100(2):274-9. View

10.

AL-KASSAB S, Dittmann L, OLESEN H . IgG subclasses, barrier function for albumin and production of immunoglobulin G in the central nervous system. Acta Neurol Scand. 1979; 60(3):129-39. DOI: 10.1111/j.1600-0404.1979.tb02960.x. View

11.

Antel J, Arnason B, Medof M . Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol. 1979; 5(4):338-42. DOI: 10.1002/ana.410050406. View

12.

Johnson W, Kohn P, Steinberg A . Population genetics of the human allotypes Gm, Inv, and A2m. Clin Immunol Immunopathol. 1977; 7(1):97-113. DOI: 10.1016/0090-1229(77)90034-4. View

13.

Laurenzi M, Mavra M, Link H . Oligoclonal IgG and free chains in multiple sclerosis demonstrated by thin-layer polyacrylamide gel isoelectric focusing and immunofixation. Ann Neurol. 1980; 8(3):241-7. DOI: 10.1002/ana.410080304. View

14.

Link H, Moller E, Norrby E . Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF. Acta Neurol Scand. 1979; 59(6):297-308. DOI: 10.1111/j.1600-0404.1979.tb02940.x. View

15.

Santoli D, Moretta L, Lisak R, Gilden D, KOPROWSKI H . Imbalances in T cell subpopulations in multiple sclerosis patients. J Immunol. 1978; 120(4):1369-71. View

16.

Griffing W, Moore S, Luthra H, McKenna C, Fathman C . Associations of antibodies to native DNA with HLA-DRw3. A possible major histocompatibility complex-linked human immune response gene. J Exp Med. 1980; 152(2 Pt 2):319s-325s. View

17.

Whittingham S, Mathews J, Schanfield M, Matthews J, Tait B, Morris P . Interactive effect of Gm allotypes and HLA-B locus antigens on the human antibody response to a bacterial antigen. Clin Exp Immunol. 1980; 40(1):8-15. PMC: 1536964. View

18.

Tiwari J, Hodge S, Terasaki P, Spence M . HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees. Am J Hum Genet. 1980; 32(1):103-11. PMC: 1685937. View

19.

PALMER D, Minard B, CAWLEY L . Letter: IgG subgroups in cerebrospinal fluid in multiple sclerosis. N Engl J Med. 1976; 294(8):447-8. DOI: 10.1056/nejm197602192940821. View

20.

Reinherz E, Weiner H, Hauser S, Cohen J, Distaso J, Schlossman S . Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med. 1980; 303(3):125-9. DOI: 10.1056/NEJM198007173030303. View